1-3 of 3
Ulrich JM Mey
Close
Sort by
Journal Articles

Multicenter Phase II Trial of Bendamustine, Lenalidomide and Dexamethasone (BRd) As 2 nd -Line Therapy for Multiple Myeloma

Ulrich JM Mey, Wolfram Brugger, MD, Mario Bargetzi, Heike Schwarb, MD, Andreas Schwarzer, MD, Tobias Dechow, MD, Paul Jehner, MD, Jacqueline Rauh, MD, Christian J. Taverna, MD, Mathias Schmid, MD, Martin Schmidt-Hieber, MD, Steffen Doerfel, Natalie Fischer, MD, Axel Ruefer, MD, Carsten Ziske, MD, Wolfgang Knauf, MD, Arnd Nusch, MD, Richard Cathomas, MD, Roger von Moos, MD, Elke Hiendlmeyer, Felicitas Hitz, MD, Christoph Driessen, MD
Journal: Blood
Blood (2014) 124 (21): 4779.
https://doi.org/10.1182/blood.V124.21.4779.4779
Published: 2014
Journal Articles

SAKK 65/08: A Phase I Dose Escalation Study of Bortezomib in Combination with Nelfinavir in Patients with Advanced Hematologic Malignancies

Christoph Driessen, MD, Jürgen Bader, Marianne Kraus, PhD, Markus Jörger, MD PhD, Hilde Rosing, PhD, Gregoire Berthod, MD, Felicitas Hitz, MD, Catherine Berset, PhD, Alexandros Xyrafas, Hanne Hawle, MD, Hermann S Overkleeft, PhD, Christiana Sessa, MD, Alwin Huitema, PhD, Ulrich JM Mey, Thomas Pabst, MD, Roger von Moos, MD, Dagmar Hess, MD
Journal: Blood
Blood (2014) 124 (21): 4747.
https://doi.org/10.1182/blood.V124.21.4747.4747
Published: 2014
Journal Articles

Rituximab Plus Lenalidomide Improves the Complete Remission Rate in Comparison with Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. Primary Endpoint Analysis of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, Giovanni Martinelli, Bjorn Ostenstad, Ulrich JM Mey, Daniel Rauch, Björn E Wahlin, MD PhD, Felicitas Hitz, MD, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés J.M. Ferreri, Andreas Lohri, Urban Novak, Thilo Zander, Hanne Bersvendsen, Mario Bargetzi, Walter Mingrone, Fatime Krasniqi, Stephan Dirnhofer, Hanne Hawle, MD, Simona Berardi, Steffi Demmel, Stephanie Rondeau, Emanuele Zucca, MD
Journal: Blood
Blood (2014) 124 (21): 799.
https://doi.org/10.1182/blood.V124.21.799.799
Published: 2014